What is LOPJLB’s current signal on HLVX?

LOPJLB’s latest quantitative signal on HilleVax, Inc. (HLVX) is BUY in a BULL regime. Signals are updated daily.

What market regime is HLVX in?

HilleVax, Inc. (HLVX) is currently classified in the BULL HMM market regime on LOPJLB.

What does HilleVax, Inc. (HLVX) do?

HilleVax, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the creation and market introduction of innovative vaccines. The company's lead investigational product is HIL-214, a vaccine candidate utilizing virus-like particles, which aims to prevent moderate-to-severe acute gastroenteritis resulting from norovirus infections. Its corporate headquarters are located in Boston,…

Where is HilleVax, Inc. based / listed?

HilleVax, Inc. is based in US, listed on NASDAQ.

HilleVax, Inc. (HLVX)

Healthcare · Biotechnology · NASDAQ · US

$2.09+0.00%Close

BUYBULL · day 18

[SCORES & PROFILE]

FUND: 13
VALUE: 22
GROWTH: 45
GARP: 6
TYPE: Value / Recovery (blended)

Composite of Value · Growth · GARP

ROIC-4.6%

REV YoY-

ROE-7.6%

EPS YoY-

ROA-6.5%

GROSS

NET

[VALUATION]

P/E TTM-9.09

P/E FWD-

SECTOR PE22.57

INDUSTRY PE17.06

P/B0.71

P/FCF-

EV/EBITDA-6.72

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E15.93

ALTMAN Z-

CURR RATIO26.39

ND/EBITDA-

BETA0.77

HilleVax, Inc. (HLVX)

Key stats

Sector peers

Industry peers

Prediction markets

FUNDAMENTALS

Company news